ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733252 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733252; 2) Community: the network communities that were significantly associated with the response to NSC 733252; 3) Molecule: the relationships between components within communities and NSC 733252; 4) MDR: the compounds that were significantly associated with the NSC 733252.

NSC Compound Enrichment Correlation
NSC 734982 Ethyl 4-[6-(2-furyl)-2-(methylsulfanyl)-4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl]butanoate 0.0352786308082227 0.036137774
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0352786308082228 0.26275193
NSC 629595 Null 0.0352786308082228 0.1910113
NSC 668259 Null 0.0352786308082228 0.26311177
NSC 119875 Cisplatin 0.0415729612483928 0.10228146
NSC 140701 Sulfanilanilide, 4'-(9-acridinylamino)-, monohydrochloride 0.0415729612483928 -0.023568002
NSC 295500 Camptothecin Derivative 0.0415729612483928 0.067999079
NSC 46728 Crassin acetate 0.0415729612483928 0.14569027
NSC 59984 Null 0.0415729612483928 0.30114106
NSC 626874 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride 0.0415729612483928 0.084574731
Total:25  Current:17    [First] [Prev] [Next] [Last]